TPI
CRL icon

Trust Point Inc’s Charles River Laboratories CRL Stock Holding History

Trust Point Inc’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,535
Closed -$265K – 513
2026
Q1 		$265K Buy
1,535
+25
+2% +$4.63K 0.02% 427
2025
Q4 		$301K Buy
+1,510
New +$274K 0.02% 371
2025
Q2 		– Sell
-2,011
Closed -$303K – 431
2025
Q1 		$303K Sell
2,011
-34
-2% -$5.7K 0.03% 339
2024
Q4 		$378K Buy
+2,045
New +$394K 0.03% 360

Other funds holding CRL

CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
IHL
Investment House LLC Redondo Beach, California $1.92B AUM 25.81% 1-Year Est. Return
CPCPP
Canada Post Corporation Pension Plan Toronto, Canada $2.87B AUM 37.96% 1-Year Est. Return
P
PensionDanmark Copenhagen O, Denmark $12B AUM
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Trust Point Inc's CRL Position: Q2 2026 in Review

Trust Point Inc sold out of Charles River Laboratories (CRL) in Q2 2026, closing a stake of 1,535 shares — an estimated $265K sold.

Trust Point Inc first reported a position in CRL in Q4 2024 and held it in 4 quarters. The position peaked at $378K in Q4 2024. 90 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Trust Point Inc reported no remaining Charles River Laboratories position as of Q2 2026 after selling out during the quarter.
  • Trust Point Inc sold 1,535 Charles River Laboratories shares in Q2 2026, an estimated $265K.
  • Trust Point Inc first reported a position in Charles River Laboratories in Q4 2024 and held it in 4 quarters.
  • Trust Point Inc's Charles River Laboratories position peaked at $378K in Q4 2024.
  • 90 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Trust Point Inc's 13F filing for Q2 2026, filed 8 Jul 2026.